期刊文献+

膀胱癌易感性与巨噬细胞移动抑制因子基因-173G〉C多态性位点的关系 被引量:3

The -173G 〉 C polymorphism in the MIF gene and bladder cancer risk
原文传递
导出
摘要 目的探讨巨噬细胞移动抑制因子(MIF)基因-173G〉C位点多态性与中国南方汉族人群膀胱癌的关系。方法用聚合酶链反应.限制性片段长度多态性(PCR—RFLP)检测年龄和性别匹配的中国南方汉族217例膀胱癌患者和249例正常人群的MIF-173G〉C基因型。通过分层分析探讨年龄、性别、吸烟和饮酒对罹患膀胱癌的影响。结果与-173GG比较,携带MIF-173GC/CC基因型者可降低罹患膀胱癌的危险性(OR=0.63,95%CI=0.43~0.93)。分层分析结果显示,年龄大(〉55岁)的男性在吸烟和饮酒下携带-173GC/CC基因型具有保护作用(年龄〉55岁:OR=0.58,95%CI=0.38~0.89;男性:0.51、0.33~0.78;吸烟:0.50、0.29~0.86;饮酒:0.40、0.23~0.70)。结论MIF-173G〉C多态性可能与我国汉族人群膀胱癌发生有关。 Objective To investigate the association between the - 173G 〉 C polymorphism in the macrophage migration inhibitory factor (MIF) gcnc and bladder cancer risk in a southern Chinese population. Methods The polymorphism was analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique using genomic DNA isolated from 217 bladder cancer patients, and 249 age-and sex-matched controls. Stratification analysis by age, sex, smoking status, and alcohol status was performed. Results Compared with the - 173GG genotype,individuals with GC/CC genotypes had a significantly decreased risk of bladder cancer ( OR = 0.63,95% CI = 0. 43-0.93 ). The stratification analysis revealed that the decreased risk was more pronounced among older subjects (0.58,0.38- 0.89) ,men (0.51,0.33-0.78) ,smokers (0.50,0.29-0.86) ,and drinkers (0.40,0.23-0.70). Conclusion Our data suggest that MIF-173G 〉 C polymorphism may contribute to the etiology of bladder cancer in a southern Chinese population.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第10期1250-1252,共3页 Chinese Journal of Experimental Surgery
关键词 巨噬细胞移动抑制因子 基因多态性 膀胱癌 分子流行病学 MIF Polymorphism Bladder carcinoma Molecular epidemiology
  • 相关文献

参考文献11

  • 1钱建民,王学浩,李国强,孙跃明,张浩.肝癌患者转化生长因子-β_1及其受体的表达和意义[J].中华实验外科杂志,2000,17(6):535-536. 被引量:5
  • 2王文清,邱双健,吴志全,樊嘉,叶胜龙,李新丰,叶超平.肝细胞癌根治性切除术后复发转移与血清转化生长因子-β1的关系[J].中华实验外科杂志,2005,22(1):100-101. 被引量:18
  • 3徐茜,刘福安,吴莺,赵赟,吴剑宏,龚建平,马丁.转化生长因子-β1对乳腺癌细胞株增殖和T淋巴细胞免疫的影响[J].中华实验外科杂志,2005,22(6):695-697. 被引量:5
  • 4Donn RP, Shelley E, Ollier WE, et al. A novel 5' -flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum, 2001, 44 : 1782-1785.
  • 5Parkin DM. International variation. Oncogene ,2004,23:6329-6340.
  • 6Franekova M, Halasova E, Bukovska E, et al. Gene polymorpbisms in bladder cancer. Urol Oncol,2008,26 : 1-8.
  • 7Cohen SM, Shirai T, Steineck G. Epiderniology and etiology of premalignant and malignant urothelial changes. Seand J Urol Nephrol Suppl,2000 : 105-115.
  • 8Kaznowska E, Przybylowska K, Kulig A. The-173 G/C polymorphism of the promoter region macrophage migration inhibitory factor gene is not associated with incidence of pulmonary hamartoma. Pol J Pathol, 2007,58 : 189-192.
  • 9Meyer-Siegler KL, Vera PL, Iczkowski KA, et al. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun,2007 ,8 :646-652.
  • 10Wei Q, Matanoski GM, Farmer ER, et al. DNA repair and aging in basal cell carcinoma:a molecular epidemiology study. Proc Natl Acad Sci USA, 1993,90 : 1614-1618.

二级参考文献19

  • 1Derynck R, Akhurst RJ, Balmain A. TGFβ signaling in tumor suppression and cancer progression. Nature Genetics, 2001, 29:117-129.
  • 2Akhurst RJ. TGF-β antagonists: Why suppress a tumor suppressor? J Clin Invest, 2002,109 : 1533-1536.
  • 3Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin in Genet Dev. 2002.12: 22-29.
  • 4Song BC, Chung YH, Kim JA, et al. Transforming growth factor- beta 1 as a useful serologic marker of small hepatocellular carcinoma. Carcer,2002, 94:175-180.
  • 5Tsai JF, Chuang LY, Jeng JE, et al. Clinical relevance of transforming growth factor-bate 1 in the urine of patients with hepatocellar carcinoma. Medicine (Baltimore), 1997, 76:213-226.
  • 6Bedossa P, Terris B, Franeo D, et al. Transforming growth factor-beta 1 receptor in normal, cirrhotic and neoplastic human livers. Hepatology,1995, 21 : 760-766.
  • 7Kloos DU,Choi C,Wingender E.The TGF-beta-Smad network:introducing bioinformatic tools.Trends Genet,2002,18:96-103.
  • 8Chorna I,Bilyy R,Datsyuk L,et al.Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin:effect of ionizing radiation on apoptosis and TGF-beta production.Eksp Onkol,2004,26:111-117.
  • 9Tang B,Vu M,Booker T,et al.TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.J Clin Invest,2003,112:1116-1124.
  • 10Wakefield LM,Roberts AB.TGF-beta signaling:positive and negative effects on tumorigenesis.Curr Opin Genet Dev,2002,12:22-29.

共引文献25

同被引文献28

  • 1阮黎,张旭,马鑫,郑诗,李宏召,李龙承,叶章群.膀胱移行细胞癌E-钙粘连素基因启动子C/A单核苷酸多态性与肿瘤复发的关系[J].中华实验外科杂志,2005,22(1):9-11. 被引量:14
  • 2Jelovac D, Armstrong DK. Rencent progress in the diagnosis and treatment of ovarian cancer[J]. CA Cancer J Clin, 2011, 61(3):183-203.
  • 3Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways[J]. Carcinogenesis, 2010,31 (1) : 37-49.
  • 4Hagemann T, Robinson SC, Thompson RG, et al. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression,and angiogenesis[J]. Mol Cancer Ther, 2007,6(7): 1993-2002.
  • 5Hagemann T, Wilson J, Kulbe H, et ai. Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK[J].J Immnol,2005,175(2):1197-1205.
  • 6Barton A, Lamb R, Symmons D, et al. Macrophage migration inhibitory factor (MIF) genepolymorphism is associated with susceptibility to hut not severity of inflammatory polyarthritis [J]. Genes Immun, 2003,4(7) :487-491.
  • 7Meyer-Siegler KL, Vera PL, Iczkowski KA, et al. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence[J]. Genes Immun, 2007,8 (8) : 646-652.
  • 8Arisawa T, Tahara T, Shibata T, et al. Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis[J]. Oncol Rep, 2008,19 (1) : 223-228.
  • 9Xue Y, Xu H, Rong L, et al. The MIF -173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population[J]. Leuk Res, 2010,34(10): 1282-1286.
  • 10Smith AJ, Humphries SE. Cytokine and cytokine receptor gene poly- morphisms and their functionality. Cytokine Growth Factor Rev ,2009, 20:43-59.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部